Patent · US Active

Compositions and methods for cancer therapy

US11365250B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Bruce Beutler · Dallas, US
Evan Nair-Gill · Los Angeles, US
Xue Zhong · Gungahlin, AU
Jinglei Zhang · Beijing, CN
Pingping Wang · Shanghai, CN

Key dates

Filing date	Nov 29, 2018
Grant date	Jun 21, 2022
Priority date	—
Expiry date	Nov 29, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure generally relates to compositions and methods for cancer immunotherapy, as well as hematopoietic recovery following cancer treatment such as chemotherapy or irradiation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.